novo industri earning fall increase sale danishbase insulin enzyme producer novo industri as nvoco pretax earning fall 10 pct 1986 sale rise pct pretax figure fall 788 mln crown 872 mln 1985 sale increase 41 billion 42 billion give net earning 521 mln crown 604 mln 1985 earning 20crown share 2379 crown 2045 crown company propose unchanged 20 pct dividend foreign exchange fluctuation 1986 significant factor development result tax novo statement not us dollar currency essential novo fall 1986 relation danish crown statement add november 1986 novo purchase 75 pct share as ferrosan heads group specialise research development cns central nervous treatment treatment sale pharmaceutical vitamin scandinavia 357 mln crown pay goodwill have limit effect 1986 result novo statement say